There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

A recent poll highlights how the pursuit of weight loss has quietly become a costly, long-term financial burden for many Americans.

Getting (and staying) fit isn’t cheap. In A Nutshell Americans trying to lose weight say they spent an average of $12,308 in one year. Many are shifting away from quick fixes toward slower, more ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets patients openly request help and gives doctors the tools to focus entire ...

Avoid these weight loss journey pitfalls with our expert tips.

Make your running for weight loss journey one that goes beyond the numbers.